Jang IJ - Search Results

1

Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial.

Kim DW, Lee DH, Han JY, Lee J, Cho BC, Kang JH, Lee KH, Cho EK, Kim JS, Min YJ, Cho JY, An HJ, Kim HG, Lee KH, Kim BS, Jang IJ, Yoon S, Han O, Noh YS, Hong KY, Park K. Kim DW, et al. Among authors: jang ij. Lung Cancer. 2019 Sep;135:66-72. doi: 10.1016/j.lungcan.2019.07.007. Epub 2019 Jul 9. Lung Cancer. 2019. PMID: 31447004 Clinical Trial.

2

Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin.

Han JY, Lim HS, Shin ES, Yoo YK, Park YH, Lee JE, Jang IJ, Lee DH, Lee JS. Han JY, et al. Among authors: jang ij. J Clin Oncol. 2006 May 20;24(15):2237-44. doi: 10.1200/JCO.2005.03.0239. Epub 2006 Apr 24. J Clin Oncol. 2006. PMID: 16636344

3

Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers.

Yoon S, Lee H, Kim TE, Lee S, Chee DH, Cho JY, Yu KS, Jang IJ. Yoon S, et al. Among authors: jang ij. Drug Des Devel Ther. 2014 Jan 15;8:123-8. doi: 10.2147/DDDT.S53027. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 24470753 Free PMC article. Clinical Trial.

4

Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state.

Jang K, Yoon S, Kim SE, Cho JY, Yoon SH, Lim KS, Yu KS, Jang IJ, Lee H. Jang K, et al. Among authors: jang ij. Drug Des Devel Ther. 2014 Jun 25;8:851-8. doi: 10.2147/DDDT.S62176. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25028536 Free PMC article. Clinical Trial.

5

Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors.

Oh DY, Kim TM, Han SW, Shin DY, Lee YG, Lee KW, Kim JH, Kim TY, Jang IJ, Lee JS, Bang YJ. Oh DY, et al. Among authors: jang ij. Cancer Res Treat. 2016 Jan;48(1):28-36. doi: 10.4143/crt.2014.258. Epub 2015 Feb 23. Cancer Res Treat. 2016. PMID: 25715767 Free PMC article. Clinical Trial.

6

Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects.

Yoon S, Shin D, Lee H, Jang IJ, Yu KS. Yoon S, et al. Among authors: jang ij. Drug Des Devel Ther. 2015 Aug 31;9:5033-49. doi: 10.2147/DDDT.S86884. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26357467 Free PMC article. Clinical Trial.

7

Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.

Yoon S, Park KR, Lee S, Song SH, Park WB, Jang IJ, Yu KS. Yoon S, et al. Among authors: jang ij. Basic Clin Pharmacol Toxicol. 2018 Feb;122(2):233-238. doi: 10.1111/bcpt.12873. Epub 2017 Sep 6. Basic Clin Pharmacol Toxicol. 2018. PMID: 28834212 Free article.

8

Pharmacokinetic characteristics of telaprevir in healthy Korean male subjects and comparisons with Japanese.

Choi Y, Yoon S, Matsumoto K, Ohta Y, Lee S, Yu KS, Jang IJ. Choi Y, et al. Among authors: jang ij. Drug Des Devel Ther. 2018 Apr 30;12:1045-1051. doi: 10.2147/DDDT.S148117. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29750017 Free PMC article.

9

Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction.

Kim DJ, Yoon S, Ji SC, Yang J, Kim YK, Lee S, Yu KS, Jang IJ, Chung JY, Cho JY. Kim DJ, et al. Among authors: jang ij. Sci Rep. 2018 Aug 8;8(1):11874. doi: 10.1038/s41598-018-30349-1. Sci Rep. 2018. PMID: 30089798 Free PMC article. Clinical Trial.

10

A safety, pharmacokinetic, pharmacogenomic and population pharmacokinetic analysis of the third-generation EGFR TKI, olmutinib (HM61713), after single oral administration in healthy volunteers.

Noh YS, Yoon S, Kim SR, Lee KT, Jang IJ. Noh YS, et al. Among authors: jang ij. Basic Clin Pharmacol Toxicol. 2019 Oct;125(4):370-381. doi: 10.1111/bcpt.13262. Epub 2019 Jun 28. Basic Clin Pharmacol Toxicol. 2019. PMID: 31125491 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page